Thursday, December 12 at 11 AM EST

This event will feature Dr. Volker Straub, a renowned neuromuscular genetics expert, Director of the John Walton Muscular Dystrophy Research Centre at Newcastle University, and member of C3’s Scientific Advisory Board. Dr. Straub will provide an overview of Limb-Girdle Muscular Dystrophies and highlight critical unmet needs in the field. He’ll be joined by a panel of experts including C3 Scientific Director Jennifer Levy, Douglas Sproule (ML Biosolutions), Kathryn Bryant Knudson (The Speak Foundation), Sophie Olivier (Atamyo Therapeutics), and Cécile Ollivier (the Critical-Path Institute).

Together, they’ll explore how the launch of the LGMDs Task Force aims to foster data sharing across LGMD subtypes, drive innovation in drug development, and inspire new researchers to enter the field.

What you’ll gain:
▶ Learn about cutting-edge initiatives to address challenges in LGMD research.
▶Hear diverse perspectives from advocacy leaders, industry stakeholders, and leading scientists.
▶Discover how collaboration in a pre-competitive, neutral environment can accelerate progress for LGMDs.

Don’t miss this opportunity to be part of a conversation that could shape the future of LGMD drug development.

🔗 Register now: https://c-path-org.zoom.us/webinar/register/WN_1FF-WoZ8TaSrEeZE6t79dA#/registration

Upcoming webinar: The Power of Data Sharing and Collaboration Across LGMDs in a Pre-Competitive, Neutral Environment